Clinic
Wilmington Urgent Care and Family Clinic INC
Wilmington Urgent Care and Family Clinic INC was paid $7.25M by Medicaid between Jan 2018 and Oct 2024, across 49 billing codes. Its largest line is 0225U, — 31% of everything it billed.
33Billing provider infoWILMINGTON URGENT CARE AND FAMILY CLINIC INC
WILMINGTON, CA 90744
WILMINGTON, CA 90744
33aNPI1972863611assigned 05/28/2012
33bProvider typeUrgent Care Clinic/Center
28Total paid$7.25M
24GClaims127,908
24DCodes billed49
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#24 of 284
Median peer was paid$147K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,083 | $131K | |
| 2019 | 11,946 | $261K | |
| 2020 | 6,224 | $133K | |
| 2021 | 9,996 | $216K | |
| 2022 | 52,347 | $3.90M | |
| 2023 | 22,793 | $1.86M | |
| 2024incomplete | 16,519 | $747K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0225U | 31% | 7,234 | 5,583 | $2.27M | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 20% | 8,880 | 7,181 | $1.48M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 12% | 6,442 | 4,553 | $849K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 7.0% | 10,992 | 8,603 | $510K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.8% | 6,705 | 4,664 | $417K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.9% | 18,737 | 15,825 | $358K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 5,630 | 4,873 | $226K |
| S9083 | Global fee urgent care centers | 2.4% | 3,790 | 3,392 | $175K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 8,917 | 7,853 | $159K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.7% | 6,618 | 4,623 | $121K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 3,640 | 3,430 | $120K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 2,688 | 2,641 | $118K |
37 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.3% | 5,336 | $95K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 1,582 | $87K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 3,248 | $62K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,186 | $56K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 6,311 | $46K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,286 | $42K |
| 99205 | Prolong outpt/office vis | <1% | 426 | $24K |
| 99072 | <1% | 7,732 | $22K | |
| 81002 | <1% | 2,899 | $6K | |
| 0224U | <1% | 125 | $4K | |
| 81025 | <1% | 1,524 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 138 | $1K |
| 93000 | <1% | 542 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 486 | $935.45 |
| 0003A | <1% | 16 | $640.00 | |
| 0013A | <1% | 16 | $600.00 | |
| 99000 | <1% | 852 | $503.10 | |
| 36410 | <1% | 295 | $480.47 | |
| 99401 | <1% | 284 | $388.19 | |
| 0011A | <1% | 14 | $380.00 | |
| 82947 | <1% | 101 | $219.27 | |
| 81000 | <1% | 388 | $200.89 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $170.34 |
| 85018 | <1% | 84 | $115.92 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 27 | $108.86 |
| 99402 | <1% | 35 | $60.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 105 | $54.87 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 40 | $28.61 |
| 81003 | <1% | 45 | $28.53 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $11.70 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 83 | $10.59 |
| 36415 | Collection of venous blood by venipuncture | <1% | 299 | $3.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 13 | $0.00 |
| 3074F | 0% | 29 | $0.00 | |
| 88150 | 0% | 26 | $0.00 | |
| 3078F | 0% | 17 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAHEN, PAYAM (MEDICAL DIRECTOR)